Medipower (Overseas) Public Co. Limited (MDPR.TA)
ILA 645.5
(3.93%)
ILA 645.5
(3.93%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 275.2 Million USD | -4.6% |
| 2022 | 288.49 Million USD | -1.13% |
| 2021 | 291.79 Million USD | 58.3% |
| 2020 | 184.32 Million USD | 31.27% |
| 2019 | 140.41 Million USD | 20.18% |
| 2018 | 116.83 Million USD | -5.6% |
| 2017 | 123.76 Million USD | 31.45% |
| 2016 | 94.15 Million USD | 46.35% |
| 2015 | 64.33 Million USD | -26.37% |
| 2014 | 87.37 Million USD | -5.6% |
| 2013 | 92.55 Million USD | -75.8% |
| 2012 | 382.43 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 234.46 Million USD | -14.81% |
| 2023 Q1 | 253.04 Million USD | -12.29% |
| 2023 Q4 | 275.2 Million USD | 11.39% |
| 2023 FY | 275.2 Million USD | -4.6% |
| 2023 Q3 | 247.07 Million USD | -1.54% |
| 2023 Q2 | 250.94 Million USD | -0.83% |
| 2022 Q4 | 288.49 Million USD | 11.85% |
| 2022 Q2 | 259.62 Million USD | 6.69% |
| 2022 Q1 | 243.35 Million USD | -16.6% |
| 2022 FY | 288.49 Million USD | -1.13% |
| 2022 Q3 | 257.93 Million USD | -0.65% |
| 2021 Q3 | 261.79 Million USD | 51.39% |
| 2021 Q2 | 172.92 Million USD | 0.11% |
| 2021 Q1 | 172.73 Million USD | -6.29% |
| 2021 FY | 291.79 Million USD | 58.3% |
| 2021 Q4 | 291.79 Million USD | 11.46% |
| 2020 Q2 | 166.41 Million USD | 0.43% |
| 2020 Q3 | 166.31 Million USD | -0.06% |
| 2020 Q4 | 184.32 Million USD | 10.83% |
| 2020 FY | 184.32 Million USD | 31.27% |
| 2020 Q1 | 165.69 Million USD | 18.0% |
| 2019 Q2 | 104.65 Million USD | 2.23% |
| 2019 FY | 140.41 Million USD | 20.18% |
| 2019 Q4 | 140.41 Million USD | 34.75% |
| 2019 Q1 | 102.37 Million USD | -12.38% |
| 2019 Q3 | 104.2 Million USD | -0.43% |
| 2018 Q4 | 116.83 Million USD | 13.5% |
| 2018 FY | 116.83 Million USD | -5.6% |
| 2018 Q2 | 105.8 Million USD | -0.88% |
| 2018 Q3 | 102.94 Million USD | -2.7% |
| 2018 Q1 | 106.73 Million USD | -13.76% |
| 2017 FY | 123.76 Million USD | 31.45% |
| 2017 Q4 | 123.76 Million USD | 41.72% |
| 2017 Q3 | 87.33 Million USD | 15.92% |
| 2017 Q2 | 75.34 Million USD | 10.44% |
| 2017 Q1 | 68.21 Million USD | -27.55% |
| 2016 Q2 | 55.82 Million USD | 49.77% |
| 2016 Q1 | 37.27 Million USD | -42.06% |
| 2016 FY | 94.15 Million USD | 46.35% |
| 2016 Q4 | 94.15 Million USD | 99.62% |
| 2016 Q3 | 47.16 Million USD | -15.51% |
| 2015 Q2 | 53.71 Million USD | -11.66% |
| 2015 Q4 | 64.33 Million USD | 22.72% |
| 2015 Q3 | 52.42 Million USD | -2.39% |
| 2015 FY | 64.33 Million USD | -26.37% |
| 2015 Q1 | 60.8 Million USD | -30.42% |
| 2014 Q2 | 54.7 Million USD | -15.2% |
| 2014 FY | 87.37 Million USD | -5.6% |
| 2014 Q1 | 64.51 Million USD | -30.3% |
| 2014 Q3 | 57.29 Million USD | 4.74% |
| 2014 Q4 | 87.37 Million USD | 52.5% |
| 2013 FY | 92.55 Million USD | -75.8% |
| 2013 Q2 | 62.88 Million USD | -7.09% |
| 2013 Q4 | 92.55 Million USD | 0.0% |
| 2013 Q1 | 67.68 Million USD | -82.3% |
| 2012 FY | 382.43 Million USD | 0.0% |
| 2012 Q4 | 382.43 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|